The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...
The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.
Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.
Pfizer Inc. defeated a lawsuit from Texas Attorney General Ken Paxton that alleged the pharmaceutical giant misrepresented ...
A new study claims Pfizer Covid-19 vaccines contain DNA contamination levels exceeding regulatory safety limits by up to 470 ...
PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...
A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.
Joe Rogan is a known critic of COVID-19 vaccines. So, on a past episode of his podcast, episode #2029 to be exact, he detailed his feelings on the matter to fellow comedian Bill Maher.
Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...
Coronavirus Disease 2019 (COVID-19) + influenza vaccine is under clinical development by Pfizer and currently in Phase II for Influenzavirus A Infections.
University of Pennsylvania will receive $467 million from BioNTech as part of a settlement in a lawsuit over COVID-19 vaccine ...
Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...